The rating assignment is based on a number of factors, including UAB Medicine’s solid market share in Birmingham, as well as its affiliations with Birmingham-based University of Alabama School of Medicine, the University of Alabama at Birmingham and Tuscaloosa-based University of Alabama System.
The outlook is positive, reflecting Moody’s Investors Service’s expectation that UAB Medicine will continue to capitalize on recent organizational changes and continue to increase operating cash flow.
More articles on healthcare finance:
4 healthcare organizations HFMA points to as great in consumerism
September Recap: 10 things for RCM leaders to know
Moody’s upgrades, affirms Parkview Health System’s bonds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
